Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cong Xia
Institution:
Tianjin Medical University Cancer Institute and Hospital
Observed institution:
Tianjin Medical University Cancer Institute and Hospital
ORCID:
0009-0002-6553-425X
Observed ORCID:
0009-0002-6553-425X
OpenAlex ID:
A5109376589
CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
·
Cancer Research
·
12
Data from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
·
1
Figure S1 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S4 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S11 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S14 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S10 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S3 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S6 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S7 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S13 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S8 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S2 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Figure S12 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S9 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
PDF
Figure S5 from CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance
2025
·
Meixi Wang
, Fangdi Zou
, et al.
Show more works
View as search
Works count:
16
Citation count:
13
H-index:
1
I10-index:
1
Year
Topic
Type